US20030171578A1 - Pyrrolidinone derivative compound - Google Patents
Pyrrolidinone derivative compound Download PDFInfo
- Publication number
- US20030171578A1 US20030171578A1 US10/369,808 US36980803A US2003171578A1 US 20030171578 A1 US20030171578 A1 US 20030171578A1 US 36980803 A US36980803 A US 36980803A US 2003171578 A1 US2003171578 A1 US 2003171578A1
- Authority
- US
- United States
- Prior art keywords
- group
- formula
- carbon atoms
- compound
- given above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Pyrrolidinone derivative compound Chemical class 0.000 title claims abstract description 37
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 75
- 150000001875 compounds Chemical class 0.000 claims abstract description 48
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 37
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 23
- 125000005843 halogen group Chemical group 0.000 claims abstract description 13
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims abstract description 11
- FDKLLWKMYAMLIF-UHFFFAOYSA-N cyclopropane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CC1 FDKLLWKMYAMLIF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 125000003277 amino group Chemical group 0.000 claims abstract description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 37
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 36
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 150000001412 amines Chemical class 0.000 claims description 14
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 26
- 239000002994 raw material Substances 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- 239000002904 solvent Substances 0.000 description 19
- 0 [21*]C1=C([22*])C([23*])=C([24*])C([25*])=C1N1CCC(C(=O)O)C1=O Chemical compound [21*]C1=C([22*])C([23*])=C([24*])C([25*])=C1N1CCC(C(=O)O)C1=O 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- ANLNOUYHIMXGKJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-oxopyrrolidine-3-carboxylic acid Chemical compound O=C1C(C(=O)O)CCN1C1=CC=C(Cl)C=C1 ANLNOUYHIMXGKJ-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- DKVVPXLIRYCKCS-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]pyrrolidin-2-one Chemical compound C1CN(CCOC)CCN1CC1C(=O)N(C=2C=CC(Cl)=CC=2)CC1 DKVVPXLIRYCKCS-UHFFFAOYSA-N 0.000 description 4
- NXHUHEUOFBLGGT-UHFFFAOYSA-N CC.CCC1=CC=CC=C1 Chemical compound CC.CCC1=CC=CC=C1 NXHUHEUOFBLGGT-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- BMEMBBFDTYHTLH-UHFFFAOYSA-N 1-(2-methoxyethyl)piperazine Chemical compound COCCN1CCNCC1 BMEMBBFDTYHTLH-UHFFFAOYSA-N 0.000 description 3
- YYCDXJBGUIRHBL-UHFFFAOYSA-N 1-(4-bromophenyl)-3-methylidenepyrrolidin-2-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(=C)CC1 YYCDXJBGUIRHBL-UHFFFAOYSA-N 0.000 description 3
- QXUKQVJLHGWFCI-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-methylidenepyrrolidin-2-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(=C)CC1 QXUKQVJLHGWFCI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000020925 Bipolar disease Diseases 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- 208000010412 Glaucoma Diseases 0.000 description 3
- 206010061598 Immunodeficiency Diseases 0.000 description 3
- 208000029462 Immunodeficiency disease Diseases 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- 208000008469 Peptic Ulcer Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 206010070863 Toxicity to various agents Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 208000028683 bipolar I disease Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000003518 caustics Substances 0.000 description 3
- 208000015114 central nervous system disease Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 230000007813 immunodeficiency Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 229920002866 paraformaldehyde Polymers 0.000 description 3
- 208000011906 peptic ulcer disease Diseases 0.000 description 3
- 150000004040 pyrrolidinones Chemical class 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 201000000980 schizophrenia Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VNZLQLYBRIOLFZ-UHFFFAOYSA-N 1-(2-methoxyphenyl)piperazine Chemical compound COC1=CC=CC=C1N1CCNCC1 VNZLQLYBRIOLFZ-UHFFFAOYSA-N 0.000 description 2
- IUDCNJTXDHUOFW-UHFFFAOYSA-N 1-(4-bromophenyl)-3-(pyrrolidin-1-ylmethyl)pyrrolidin-2-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(CN2CCCC2)CC1 IUDCNJTXDHUOFW-UHFFFAOYSA-N 0.000 description 2
- BPCHRGWDFLCLIV-UHFFFAOYSA-N 1-(4-bromophenyl)-3-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]pyrrolidin-2-one Chemical compound C1CN(CCOC)CCN1CC1C(=O)N(C=2C=CC(Br)=CC=2)CC1 BPCHRGWDFLCLIV-UHFFFAOYSA-N 0.000 description 2
- XTMAKZPKUCICML-UHFFFAOYSA-N 1-(4-bromophenyl)-3-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]pyrrolidin-2-one Chemical compound COC1=CC=CC=C1N1CCN(CC2C(N(CC2)C=2C=CC(Br)=CC=2)=O)CC1 XTMAKZPKUCICML-UHFFFAOYSA-N 0.000 description 2
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- RXYPXQSKLGGKOL-UHFFFAOYSA-N CN1CCN(C)CC1 Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N CN1CCNCC1 Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000005246 nonafluorobutyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- PHJMARYQKJGPKG-UHFFFAOYSA-N 1-(4-bromophenyl)-2-oxopyrrolidine-3-carboxylic acid Chemical compound O=C1C(C(=O)O)CCN1C1=CC=C(Br)C=C1 PHJMARYQKJGPKG-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- KYMHPKUQZVAQIG-UHFFFAOYSA-N 2-oxo-1-[3-(trifluoromethyl)phenyl]pyrrolidine-3-carboxylic acid Chemical compound O=C1C(C(=O)O)CCN1C1=CC=CC(C(F)(F)F)=C1 KYMHPKUQZVAQIG-UHFFFAOYSA-N 0.000 description 1
- KIXWRXJXMVUWCP-UHFFFAOYSA-N 2-oxo-1-phenylpyrrolidine-3-carboxylic acid Chemical compound O=C1C(C(=O)O)CCN1C1=CC=CC=C1 KIXWRXJXMVUWCP-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- ZEYSHALLPAKUHG-UHFFFAOYSA-N 4-methoxypiperidine Chemical compound COC1CCNCC1 ZEYSHALLPAKUHG-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- AXJVPXNVESYGDT-UHFFFAOYSA-N 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione Chemical compound O=C1OC(C)(C)OC(=O)C11CC1 AXJVPXNVESYGDT-UHFFFAOYSA-N 0.000 description 1
- KTGOFTFWXSSKLP-UHFFFAOYSA-N CCN1CN(C)C1 Chemical compound CCN1CN(C)C1 KTGOFTFWXSSKLP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KLQCQBLFKJYBGR-UHFFFAOYSA-N ethyl 1-(4-chlorophenyl)-2-oxopyrrolidine-3-carboxylate Chemical compound O=C1C(C(=O)OCC)CCN1C1=CC=C(Cl)C=C1 KLQCQBLFKJYBGR-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Definitions
- the present invention relates to a process for production of a pyrrolidinone compound which is useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc.; a 3-carboxy-1-substituted-2-pyrrolidinone compound which is a useful intermediate for production of the above pyrrolidinone compound; and a process for production of the 3-carboxy-1-substituted-2-pyrrolidinone compound.
- central nervous system disorders e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy
- diseases associated with immunodeficiency and cryptorrhea e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis,
- Pyrrolidinone compounds having a pyrrolidinone skeleton as the basic structure which are useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc., and processes for production of the compounds are disclosed in EP Publication No. 0668275A1 and Japanese Patent Application Kokai (Laid-Open) No. 40667/1997.
- central nervous system disorders e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy
- diseases associated with immunodeficiency and cryptorrhea peptic ulcer
- diabetes and complications thereof glaucoma, etc.
- processes for production of the compounds are disclosed in EP Publication No. 0668275A1 and Japanese Patent Application Kokai (
- the former process uses, as a raw material, 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione which is expensive.
- the latter process of hydrolyzing an ester compound is not preferred for a safety reason because it may use a moisture sensitive/ignitive reagent in synthesis of the ester compound. None of these processes is satisfactory for industrial application.
- An object of the present invention is to provide a process for producing the above pyrrolidinone compound useful as a pharmaceutically active ingredient, wherein the number of steps is smaller and neither hydrogen-generating substance nor corrosive substance is used.
- Another object of the present invention is to provide a process for producing a 3-carboxy-1-phenyl-2-pyrrolidinone compound useful as an intermediate for production of the above pyrrolidinone compound useful as a pharmaceutically active ingredient, without using any expensive raw material.
- Still another object of the present invention is to provide a process for producing the 3-carboxy-1-phenyl-2-pyrrolidinone without using any moisture sensitive/ignitive reagent.
- R is an alkyl group of 1 to 12 carbon atoms or a substituent represented by the formula (2):
- R 2 is a hydrogen atom, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a hydroxyl group, a cyano group, an amino group, a nitro group, a carbamoyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carboxyl group; p is an integer of 1 to 5; when p is 2 or more, each R 2 independently has the same definition as given above; and j is an integer of 0 to 2), and Q is a substituent represented by the formula (3a), (3b), (3c) or (3d):
- R 3 and R 4 are each independently a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, and R 3 and R 4 may bond to each other to form a morpholine ring;
- m and n are each independently an integer of 1 to 4
- X is a hydrogen atom, a hydroxyl group, a cyano group, a carbamoyl group, a halogen atom or an alkyl group of 1 to 4 carbon atoms
- Y is a hydrogen atom, an alkyl group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, or a substituted or unsubstituted phenyl group
- W is an alkyl group of 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or an alkyl group of 1 to 2 carbon atoms substituted with a
- k is an integer of 2 to 3; and R 5 is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms, an alkenyl group of 2 to 3 carbon atoms or an alkynyl group of 2 to 3 carbon atoms) ⁇ .
- the compound of the formula (1) is useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc.
- central nervous system disorders e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy
- diseases associated with immunodeficiency and cryptorrhea e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy
- diseases associated with immunodeficiency and cryptorrhea e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy
- diseases associated with immunodeficiency and cryptorrhea e.g.
- the present process for producing the pyrrolidinone compound of the formula (1) includes a step of reacting a compound represented by the formula (5):
- R 3 and R 4 have the same definitions as given above; in the formula (6b), X, Y, m and n have the same definitions as given above; in the formula (6c), W has the same definition as given above; and in the formula (6d), Z, m and n have the same definitions as given above ⁇ in the presence of formaldehyde to produce a pyrrolidinone compound of the formula (1).
- the 3-carboxy-1-phenyl-2-pyrrolidinone compound which is useful as a starting material (an intermediate) for production of the pyrrolidinone compound of the formula (1) is represented by the following formula (12) and is one of the compounds of the formula (5):
- R 21 to R 25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group).
- the compound of the formula (12) is useful as an intermediate for production of the pyrrolidinone compound of the formula (1) or as an intermediate for production of an agricultural chemical.
- the compound of the formula (12) can be obtained by reacting a compound of the formula (13):
- a 3-carboxy-1-phenyl-2-pyrrolidinone compound which is useful as an intermediate for production of the pyrrolidinone compound of the formula (1); and a process for producing the 3-carboxy-1-phenyl-2-pyrrolidinone compound without using any expensive raw material or without using any moisture sensitive/ignitive reagent.
- the present process for production of the compound of the formula (1) includes, as mentioned previously, a step of reacting a compound of the formula (5) with one of the compounds of the formulas (6a) to (6d) in the presence of formaldehyde.
- R 2a is a hydrogen atom or a halogen atom; p is an integer of 1 to 5; when p is 2 or more, each R 2a independently has the same definition as given above; and j a is 0), and Q is a substituent represented by the formula (7):
- a pyrrolidinone compound of the formula (1) wherein R 1 is a 4-chlorophenyl group and Q is a substituent represented by the formula (8):
- R 6 is an alkyl group of 1 to 3 carbon atoms
- R 1 is a 4-chlorophenyl group
- the amine derivative represented by the formula (9) is preferably an amine derivative of the formula (9) wherein R 6 is a methyl group.
- alkyl group of 1 to 3 carbon atoms refers to a methyl group, an ethyl group, an n-propyl group or an isopropyl group; “alkyl group of 1 to 4 carbon atoms” refers to each group mentioned above, an n-butyl group, a sec-butyl group, a tert-butyl group, an isobutyl group or the like; “alkyl group of 1 to 12 carbon atoms” refers to each group mentioned above, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group, a dodecyl group or the like; “alkyl group of 1 to 18 carbon atoms” refers to each group mentioned above, a tridecyl group, a tetradecyl group, a
- formaldehyde used in the reaction of the reaction formula (1) there can be mentioned paraformaldehyde, trioxane, aqueous solutions thereof, etc.
- the aqueous solution ordinarily has a concentration of 5 to 50% by weight.
- the formaldehyde is used in an amount of 1 to 10 moles per mole of the compound of the general formula (5).
- the solvent used in the reaction there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; acetonitrile; and so forth.
- solvents can be used singly or in admixture.
- the reaction may be conducted without using any solvent.
- the reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- the reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- R 1 has the same definition as in the general formula (1) ⁇ is formed as an intermediate. This intermediate may be reacted with the amine of the general formula (6a), (6b), (6c) or (6d).
- This reaction may be conducted in an equimolar ratio.
- the amine may be used in excess.
- the solvent used in the reaction there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; ketones such as acetone, methyl ethyl ketone and the like; acetonitrile; and so forth.
- solvents can be used singly or in admixture.
- the reaction may be conducted without using any solvent.
- the reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- the reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- the compound of the formula (5) is preferably a compound of the formula (5) wherein R 1 is represented by the formula (2) (wherein R 2 and p have the same definitions as given above, and j is 0), or a salt thereof; more preferably a compound of the formula (5) wherein R 1 is a 4-chlorophenyl group.
- the compound of the formula (5) can be obtained by a known process, for example, by hydrolyzing, with an acid or an alkali, a compound of the general formula(11):
- R 1 has the same definition as in the formula (1), and A is an alkyl group of 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group
- the compound of the formula (11) being obtained by a process described in EP Publication No. 0668275A1 or Japanese Patent Application Kokai (Laid-Open) No.40667/1997.
- the acid there can ordinarily be used, as the acid, an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid or the like; and there can be mentioned, as the alkali, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, etc.
- an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid or the like
- the alkali sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, etc.
- the amount of the acid or alkali used is 0.1 to 100 moles, preferably 1 to 10 moles per mole of the compound of the formula (11).
- the reaction may be conducted in the presence of a phase-transfer catalyst.
- the solvent used in the reaction there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; acetonitrile; and so forth.
- solvents can be used singly or in admixture.
- the reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- the reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- the carboxylic acid obtained can be used in the next reaction as it is or in the form of a salt thereof.
- R 21 to R 25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) can be obtained by reacting a compound represented by the formula (13):
- This process as compared with the known process mentioned above, has a merit in using neither expensive raw material nor moisture sensitive/ignitive reagent.
- R 21 , R 22 , R 24 and R 25 are each a hydrogen atom and R 23 is a chlorine atom or a bromine atom; and it is more preferred that R 21 , R 22 , R 24 and R 25 are each a hydrogen atom and R 23 is a chlorine atom.
- the halogen atom includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
- the lower alkyl group of 1 to 4 carbon atoms there can be mentioned, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group and a tert-butyl group.
- the lower alkoxy group of 1 to 4 carbon atoms there can be mentioned, for example, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an n-butoxy group, an isobutoxy group, a sec-butoxy group and a tert-butoxy group.
- perfluoroalkyl group of 1 to 4 carbon atoms there can be mentioned, for example, a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, a heptafluoroisopropyl group and a nonafluorobutyl group.
- the lower alkylthio group of 1 to 4 carbon atoms there can be mentioned, for example, a methylthio group, an ethylthio group, an n-propylthio group, an isopropylthio group, an n-butylthio group, an isobutylthio group, a sec-butylthio group and a tert-butylthio group.
- the reaction of the compound of the formula (13) with 1,1-cyclopropanedicarboxylic acid can be conducted in the presence or absence of a solvent.
- a solvent there can be mentioned aromatic hydrocarbons such as benzene, toluene, xylene and the like; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, ethylene glycol dimethyl ether and the like; alcohols such as methanol, ethanol, propanol and the like; aprotic polar solvents such as dimethylformamide, dimethyl sulfoxide and the like; halogen-containing solvents such as methylene chloride, chloroform, dichloroethane and the like; carboxylic acid esters such as ethyl acetate, ethyl propionate and the like; carboxylic acids such as formic acid, acetic acid, propionic acid and the like; water
- the proportions of the compound of the formula (13) and 1,1-cyclopropanedicarboxylic acid should be determined in view of their reactivity, the formation of by-products and the economy of the reaction; however, the compound of the formula (13) is used in an amount of generally 0.1 to 10 moles, preferably 0.3 to 3 moles, more preferably 0.6 to 1.5 moles per mole of 1,1-cyclopropanedicarboxylic acid.
- the reaction temperature when a solvent is used, may range from about room temperature to the reflux temperature, preferably from 60° C. to 100° C., more preferably from 70° C. to 95° C. and, when no solvent is used, may range from about room temperature to about the melting point of reaction substrates used.
- reaction mixture was subjected to solvent removal under reduced pressure. To the residue were added an aqueous sodium hydrogencarbonate solution and ethyl acetate, and the mixture was stirred thoroughly. The aqueous layer was washed with ethyl acetate, then made acidic with hydrochloric acid, and subjected to extraction with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The resulting concentrate was sludged with diethyl ether to obtain 32.8 g of an intended compound at a crude yield of 50.2%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A compound represented by the following formula (12) useful as an intermediate for production of drug or agricultural chemical:
(wherein R21 to R25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) can be produced by reacting a compound represented by the formula (13):
(wherein R21 to R25 have the same definitions as given above) with 1,1-cyclopropanedicarboxylic acid. The compound of the formula (12) is useful as a raw material for production of a pyrrolidinone compound useful as an active ingredient of drug.
Description
- 1. Field of the Invention
- The present invention relates to a process for production of a pyrrolidinone compound which is useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc.; a 3-carboxy-1-substituted-2-pyrrolidinone compound which is a useful intermediate for production of the above pyrrolidinone compound; and a process for production of the 3-carboxy-1-substituted-2-pyrrolidinone compound.
- 2. Description of the Related Art
- Pyrrolidinone compounds having a pyrrolidinone skeleton as the basic structure, which are useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc., and processes for production of the compounds are disclosed in EP Publication No. 0668275A1 and Japanese Patent Application Kokai (Laid-Open) No. 40667/1997.
- In producing the pyrrolidinone compounds according to the above processes, however, the number of steps is large and a reduction in the number of steps has been desired for the economic reason. There has also been a problem of using a hydrogen-generating substance. There has also been a problem that a corrosive substance must be used.
- With respect to the process for production of a 3-carboxy-1-phenyl-2-pyrrolidinone compound which is useful as an intermediate for production of the above pyrrolidinone compounds, there are known, for example, a process by Danishefsky et al. described in Org. Synth., 60, 66-71, 1981; and a process of hydrolyzing an ester compound obtained by a process described in Japanese Patent Application Kokai (Laid-Open) No. 40667/1997.
- However, the former process uses, as a raw material, 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione which is expensive. Also, the latter process of hydrolyzing an ester compound is not preferred for a safety reason because it may use a moisture sensitive/ignitive reagent in synthesis of the ester compound. None of these processes is satisfactory for industrial application.
- An object of the present invention is to provide a process for producing the above pyrrolidinone compound useful as a pharmaceutically active ingredient, wherein the number of steps is smaller and neither hydrogen-generating substance nor corrosive substance is used.
- Another object of the present invention is to provide a process for producing a 3-carboxy-1-phenyl-2-pyrrolidinone compound useful as an intermediate for production of the above pyrrolidinone compound useful as a pharmaceutically active ingredient, without using any expensive raw material.
- Still another object of the present invention is to provide a process for producing the 3-carboxy-1-phenyl-2-pyrrolidinone without using any moisture sensitive/ignitive reagent.
-
-
- (wherein R 2 is a hydrogen atom, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a hydroxyl group, a cyano group, an amino group, a nitro group, a carbamoyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carboxyl group; p is an integer of 1 to 5; when p is 2 or more, each R2 independently has the same definition as given above; and j is an integer of 0 to 2), and Q is a substituent represented by the formula (3a), (3b), (3c) or (3d):
- {in the formula (3a), R 3 and R4 are each independently a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, and R3 and R4 may bond to each other to form a morpholine ring; in the formula (3b), m and n are each independently an integer of 1 to 4, X is a hydrogen atom, a hydroxyl group, a cyano group, a carbamoyl group, a halogen atom or an alkyl group of 1 to 4 carbon atoms, and Y is a hydrogen atom, an alkyl group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, or a substituted or unsubstituted phenyl group; in the formula (3c), W is an alkyl group of 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group, and in the formula (3d), m and n are each independently an integer of 1 to 4, Z is a hydrogen atom, an alkyl group of 1 to 18 carbon atoms, a substituted or unsubstituted phenyl group, an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group, or a substituent represented by the formula (4):
- —(CH2)k—OR5 (4)
- (wherein k is an integer of 2 to 3; and R 5 is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms, an alkenyl group of 2 to 3 carbon atoms or an alkynyl group of 2 to 3 carbon atoms)}.
- The compound of the formula (1) is useful as, for example, a remedy for central nervous system disorders (e.g. schizophrenia, dementia, manic depressive psychosis, anxiety neurosis, drug poisoning and ischemic encephtalopathy), diseases associated with immunodeficiency and cryptorrhea, peptic ulcer, diabetes and complications thereof, glaucoma, etc.
-
-
- (in the formula (6a), R 3 and R4 have the same definitions as given above; in the formula (6b), X, Y, m and n have the same definitions as given above; in the formula (6c), W has the same definition as given above; and in the formula (6d), Z, m and n have the same definitions as given above} in the presence of formaldehyde to produce a pyrrolidinone compound of the formula (1).
-
- (wherein R 21 to R25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group).
- The compound of the formula (12) is useful as an intermediate for production of the pyrrolidinone compound of the formula (1) or as an intermediate for production of an agricultural chemical.
-
- (wherein R 21 to R25 have the same definitions-as given above) with 1,1-cyclopropanedicarboxylic acid.
- According to the present invention, there can be provided a process for producing a pyrrolidinone compound of the formula (1), wherein the number of steps is efficiently reduced and neither hydrogen-generating substance nor corrosive substance is used.
- According to the present invention, there can also be provided a 3-carboxy-1-phenyl-2-pyrrolidinone compound which is useful as an intermediate for production of the pyrrolidinone compound of the formula (1); and a process for producing the 3-carboxy-1-phenyl-2-pyrrolidinone compound without using any expensive raw material or without using any moisture sensitive/ignitive reagent.
- The production processes of the present invention are described in detail below.
- The present process for production of the compound of the formula (1) includes, as mentioned previously, a step of reacting a compound of the formula (5) with one of the compounds of the formulas (6a) to (6d) in the presence of formaldehyde.
-
-
- (wherein m and n are each independently an integer of 1 to 4; k is an integer of 2 to 3; and R is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms, an alkenyl group of 2 to 3 carbon atoms or an alkynyl group of 2 to 3 carbon atoms)} is produced by reacting a compound of the formula (5) {wherein R 1 is a substituent represented by the formula (2a) (wherein R2a, p and ja have the same definitions as given above)} with an amine derivative represented by the formula (6d) {wherein Z is a substituent represented by the formula (4) (wherein k and R5 have the same definitions as given above)} in the presence of formaldehyde.
-
-
- (wherein R 6 has the same definition as given above) in the presence of formaldehyde.
- The amine derivative represented by the formula (9) is preferably an amine derivative of the formula (9) wherein R 6 is a methyl group.
- In the general formula (1), “alkyl group of 1 to 3 carbon atoms” refers to a methyl group, an ethyl group, an n-propyl group or an isopropyl group; “alkyl group of 1 to 4 carbon atoms” refers to each group mentioned above, an n-butyl group, a sec-butyl group, a tert-butyl group, an isobutyl group or the like; “alkyl group of 1 to 12 carbon atoms” refers to each group mentioned above, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group, a dodecyl group or the like; “alkyl group of 1 to 18 carbon atoms” refers to each group mentioned above, a tridecyl group, a tetradecyl group, a pentadecyl group, a hexadecyl group, a heptadecyl group, an octadecyl group or the like; “alkenyl group of 2 to 3 carbon atoms” refers to a vinyl group, an allyl group, a 1-propenyl group, an isopropenyl group or the like; “alkynyl group of 2 to 3 carbon atoms” refers to an ethynyl group, a 1-propynyl group, a 2-propynyl group or the like; “halogen atom” refers to a fluorine atom, a chlorine atom, a bromine atom or an iodine atom; “alkoxy group of 1 to 4 carbon atoms” refers to a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, a butoxy group or the like; “perfluoroalkyl group of 1 to 4 carbon atoms” refers to a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, a nonafluorobutyl group or the like; “alkylthio group of 1 to 4 carbon atoms” refers to a methylthio group, an ethylthio group, a propylthio group, a butylthio group or the like; “substituted phenyl group” refers to a phenyl group substituted with a halogen atom(s), an alkyl group(s) of 1 to 4 carbon atoms, an alkoxy group(s) of 1 to 4 carbon atoms, a perfluoroalkyl group(s) of 1 to 4 carbon atoms or the like; and “alkyl group of 1 to 2 carbon atoms substituted with a phenyl group” refers to a benzyl group, a phenethyl group or the like.
-
- {wherein R 1 and Q have the same definitions as in the general formula (1); and 6a, 6b, 6c and 6d have the same definitions as in the general formulas (6a) to (6d)}.
- As the formaldehyde used in the reaction of the reaction formula (1), there can be mentioned paraformaldehyde, trioxane, aqueous solutions thereof, etc. The aqueous solution ordinarily has a concentration of 5 to 50% by weight. The formaldehyde is used in an amount of 1 to 10 moles per mole of the compound of the general formula (5).
- As the solvent used in the reaction, there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; acetonitrile; and so forth. These solvents can be used singly or in admixture. The reaction may be conducted without using any solvent.
- The reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- The reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- There is no particular restriction as to the order of mixing the compound of the general formula (5), the amine derivative of the general formula (6a), (6b), (6c) or (6d) and formaldehyde. They are mixed at one time; or, the amine and formaldehyde are mixed first and then the compound of the general formula (5) is added; or, the compound of the general formula (5) and formaldehyde are mixed first and then the amine is added.
-
- {wherein R 1 has the same definition as in the general formula (1)} is formed as an intermediate. This intermediate may be reacted with the amine of the general formula (6a), (6b), (6c) or (6d).
- This reaction may be conducted in an equimolar ratio. The amine may be used in excess.
- As the solvent used in the reaction, there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; ketones such as acetone, methyl ethyl ketone and the like; acetonitrile; and so forth. These solvents can be used singly or in admixture. The reaction may be conducted without using any solvent.
- The reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- The reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- In the post-treatment after the above reaction, a purification method ordinarily used, such as column chromatography, recrystallization or the like can be used.
- The compound of the formula (5) is preferably a compound of the formula (5) wherein R 1 is represented by the formula (2) (wherein R2 and p have the same definitions as given above, and j is 0), or a salt thereof; more preferably a compound of the formula (5) wherein R1 is a 4-chlorophenyl group.
-
- (wherein R 1 has the same definition as in the formula (1), and A is an alkyl group of 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group), the compound of the formula (11) being obtained by a process described in EP Publication No. 0668275A1 or Japanese Patent Application Kokai (Laid-Open) No.40667/1997.
- In the above reaction, there can ordinarily be used, as the acid, an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid or the like; and there can be mentioned, as the alkali, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, etc.
- The amount of the acid or alkali used is 0.1 to 100 moles, preferably 1 to 10 moles per mole of the compound of the formula (11).
- The reaction may be conducted in the presence of a phase-transfer catalyst.
- As the solvent used in the reaction, there can be mentioned water; alcohols such as methanol, ethanol, isopropanol, butanol and the like; ethers such as diethyl ether, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether and the like; aromatic hydrocarbons such as benzene, toluene and xylene and the like; halogen-containing hydrocarbons such as dichloromethane, dichloroethane, chloroform and the like; acetonitrile; and so forth. These solvents can be used singly or in admixture.
- The reaction temperature may range from 0° C. to the boiling point of the solvent used, preferably from room temperature to 150° C.
- The reaction time is not particularly restricted, but is preferably 1 to 48 hours.
- The carboxylic acid obtained can be used in the next reaction as it is or in the form of a salt thereof.
-
- (wherein R 21 to R25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) can be obtained by reacting a compound represented by the formula (13):
- {wherein R 21 to R25 have the same definitions as in the formula (12)} with 1,1-cyclopropanedicarboxylic acid.
- This process, as compared with the known process mentioned above, has a merit in using neither expensive raw material nor moisture sensitive/ignitive reagent.
- In the above process, it is preferred that R 21, R22, R24 and R25 are each a hydrogen atom and R23 is a chlorine atom or a bromine atom; and it is more preferred that R21, R22, R24 and R25 are each a hydrogen atom and R23 is a chlorine atom.
- In the formulas (12) and (13), the halogen atom includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
- As the lower alkyl group of 1 to 4 carbon atoms, there can be mentioned, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group and a tert-butyl group.
- As the lower alkoxy group of 1 to 4 carbon atoms, there can be mentioned, for example, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an n-butoxy group, an isobutoxy group, a sec-butoxy group and a tert-butoxy group.
- As the perfluoroalkyl group of 1 to 4 carbon atoms, there can be mentioned, for example, a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, a heptafluoroisopropyl group and a nonafluorobutyl group.
- As the lower alkylthio group of 1 to 4 carbon atoms, there can be mentioned, for example, a methylthio group, an ethylthio group, an n-propylthio group, an isopropylthio group, an n-butylthio group, an isobutylthio group, a sec-butylthio group and a tert-butylthio group.
- The reaction of the compound of the formula (13) with 1,1-cyclopropanedicarboxylic acid can be conducted in the presence or absence of a solvent. As the solvent, there can be mentioned aromatic hydrocarbons such as benzene, toluene, xylene and the like; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, ethylene glycol dimethyl ether and the like; alcohols such as methanol, ethanol, propanol and the like; aprotic polar solvents such as dimethylformamide, dimethyl sulfoxide and the like; halogen-containing solvents such as methylene chloride, chloroform, dichloroethane and the like; carboxylic acid esters such as ethyl acetate, ethyl propionate and the like; carboxylic acids such as formic acid, acetic acid, propionic acid and the like; water; acetone; methyl ethyl ketone; and acetonitrile. These solvents can be used singly or in admixture.
- The proportions of the compound of the formula (13) and 1,1-cyclopropanedicarboxylic acid should be determined in view of their reactivity, the formation of by-products and the economy of the reaction; however, the compound of the formula (13) is used in an amount of generally 0.1 to 10 moles, preferably 0.3 to 3 moles, more preferably 0.6 to 1.5 moles per mole of 1,1-cyclopropanedicarboxylic acid.
- The reaction temperature, when a solvent is used, may range from about room temperature to the reflux temperature, preferably from 60° C. to 100° C., more preferably from 70° C. to 95° C. and, when no solvent is used, may range from about room temperature to about the melting point of reaction substrates used.
- The present invention is described more specifically below with reference to Examples. However, the present invention is not restricted by these Examples.
- Production of 3-carboxy-1-(4-chlorophenyl)-2-pyrrolidinone
- 2.0 g of 1,1-cyclopropanedicarboxylic acid and 2.9 g of 4-chloroaniline were added to 2.7 g of water. The mixture was stirred at 80° C. for 20 hours.
- To the reaction mixture were added 20 ml of a 25% aqueous NaOH solution and 20 ml of ethyl acetate, followed by thorough stirring. The aqueous layer was washed with ethyl acetate and then made acidic with hydrochloric acid. The resulting crystals were collected by filtration, then washed with water, and dried to obtain 2.2 g of an intended compound at a yield of 59.7%.
- Melting point: 170° C. (decomposed)
- 1H-NMR (DMSO, δ ppm): 2.2-2.4 (2H, m), 3.61 (1H, t), 3.8-3.95 (2H, m), 7.4-7.5 (2H, m), 7.65-7.75 (2H, m)
- Production of 1-(4-bromophenyl)-3-carboxy-2-pyrrolidinone
- 30 g of 1,1-cyclopropanedicarboxylic acid and 50 g of 4-bromoaniline were added to 50 ml of acetonitrile, followed by refluxing for 7 hours with heating and stirring.
- The reaction mixture was subjected to solvent removal under reduced pressure. To the residue were added an aqueous sodium hydrogencarbonate solution and ethyl acetate, and the mixture was stirred thoroughly. The aqueous layer was washed with ethyl acetate, then made acidic with hydrochloric acid, and subjected to extraction with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The resulting concentrate was sludged with diethyl ether to obtain 32.8 g of an intended compound at a crude yield of 50.2%.
- 1H-NMR (CDCl3, δ ppm): 2.39-2.68 (2H, m), 3.66 (1H, t), 3.85 (2H, m), 7.51 (4H, s)
- Production of 3-carboxy-1-(3-trifluoromethylphenyl)-2-pyrrolidinone
- 10.0 g of 1,1-cyclopropanedicarboxylic acid and 12.4 g of 4-trifluoromethylaniline were added to 15 ml of acetonitrile, followed by refluxing for 7 hours with heating and stirring. The subsequent operation was conducted in the same manner as in Example 2 to obtain 7.1 g of an intended compound at a yield of 38.8%.
- 1H-NMR (CDCl3, δ ppm): 2.43-2.67 (2H, m), 3.73 (1H, t), 3.97 (2H, t), 7.47-7.54 (2H, m), 7.75-7.87 (2H, m)
- Production of 3-carboxy-1-(4-chlorophenyl)-2-pyrrolidinone
- 61.8 g of 1-(4-chlorophenyl)-3-ethoxycarbonyl-2-pyrrolidinone was mixed with 45 g of ethanol. Thereto was added a solution of 46.1 g of sodium hydroxide dissolved in 100 ml of water, followed by mixing. The mixture was once made into a complete solution, after which a large amount of crystals appeared.
- Thereto was added water. The crystals were collected by filtration and washed with diethyl ether. To the filtrate was added diethyl ether, followed by stirring. The aqueous layer was separated. This aqeuous layer and the crystals were combined and made acidic with hydrochloric acid with thorough stirring. The crystals were collected by filtration and washed with water to obtain 52.5 g of 3-carboxy-1-(4-chlorophenyl)-2-pyrrolidinone.
- Melting point: 170° C. (decomposed)
- 1H-NMR (DMSO, δ ppm): 2.2-2.4 (2H, m), 3.61 (1H, t), 3.8-3.95 (2H, m), 7.4-7.5 (2H, m), 7.65-7.75 (2H, m)
- This spectrum data corresponded with that of the compound obtained by reacting p-chloroaniline with 6,6-dimethyl-5,7-dioxyaspiro[2,5]octane-4,8-dione according to the method described in Org. Synth., 60, 66-71, 1981.
- Production of 1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone
- 3.0 g of 1-(4-chlorophenyl)-3-carboxy-2-pyrrolidinone and 2.32 g of 4-(2-methoxyethyl)piperazine were mixed with 6 ml of methanol. Thereto was added 0.465 g of 80% paraformaldehyde. The mixture was subjected to a reaction for 10.5 hours under refluxing and then cooled to room temperature. Thereto was added 10 ml of methanol, and the insolubles were removed by filtration. The filtrate was concentrated under reduced pressure. The residue was mixed with 15 ml of water. The resulting crystals were collected by filtration and washed with 3 ml of 95% aqueous methanol twice to obtain 3.42 g of 1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone.
- Melting point: 103-105° C.
- 1H-NMR (CDCl3, δ ppm): 2.01-2.12 (1H, m), 2.29-2.62 (12H, m), 2.78-2.94 (2H, m), 3.35 (3H, s), 3.51 (2H, t),3.74-3.80 (2H, m), 7.32 (2H, d), 7.59 (2H, d)
- Production of 1-(4-chlorophenyl)-3-methylene-2-pyrrolidinone
- 1.56 g of 1-(4-chlorophenyl)-3-carboxy-2-pyrrolidinone was mixed with 7 ml of methanol. Thereto were added 0.26 g of 75% paraformaldehyde and 0.75 g of 4-methoxypiperidine. The mixture was refluxed for 2 hours. The reaction mixture was concentrated to dryness. The residue was purified by silica gel column chromatography using chloroform (a solvent) to obtain 0.85 g of 1-(4-chlorophenyl)-3-methylene-2-pyrrolidinone.
- Melting point: 119-120° C.
- 1H-NMR (CDCl3, δ ppm): 2.87-2.94 (2H, m), 3.83 (2H, t), 5.46 (1H, t), 6.14 (1H, t), 7.32-7.37 (2H, m), 7.67-7.73 (2H, m)
- Production of 1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone
- 0.85 g of 1-(4-chlorophenyl)-3-methylene-2-pyrrolidinone and 0.71 g of 4-(2-methoxyethyl)piperazine were mixed with 3 ml of acetonitrile. The mixture was refluxed for 3.5 hours. The reaction mixture was concentrated to dryness. The residue was purified by silica gel column chromatography using a mixed solvent (chloroform/methanol=20/1) to obtain 1.1 g of 1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone.
- Melting point: 103-105° C.
- 1H-NMR (CDCl3, δ ppm) : 2.01-2.12 (1H, m), 2.29-2.62 (12H, m), 2.78-2.94 (2H, m), 3.35 (3H, s), 3.51 (2H, t), 3.74-3.80 (2H, m) 7.32 (2H, d), 7.59 (2H, d)
- Production of 1-(4-bromophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone
- 1.31 g of 1-(4-bromophenyl)-3-methylene-2-pyrrolidinone and 1.00 g of 4-(2-methoxyethyl)piperazine were mixed with 5 ml of ethylene glycol dimethyl ether. The mixture was refluxed for 6.5 hours and then cooled. Thereto was added water. The mixture was subjected to extraction with ethyl acetate twice. The organic layer was dried over anhydrous magnesium sulfate and then concentrated to obtain 1.91 g of 1-(4-bromophenyl)-3-[4-(2-methoxyethyl)piperazine-1-yl]methyl-2-pyrrolidinone.
- 1H-NMR (CDCl3, δ ppm): 1.98-2.12 (1H, m), 2.29-2.41 (1H, m), 2.53-2.63 (11H, m), 2.78-2.94 (2H, m), 3.35 (3H, s), 3.51 (2H, t), 3.74-3.82 (2H, m), 7.46 (2H, d), 7.54 (2H, d)
- Production of 1-(4-bromophenyl)-3-[4-(2-methoxyphenyl)piperazine-1-yl]methyl-2-pyrrolidinone
- 1.31 g of 1-(4-bromophenyl)-3-methylene-2-pyrrolidinone and 2.00 g of 4-(2-methoxyphenyl)piperazine were mixed with 5 ml of ethylene glycol dimethyl ether. The mixture was refluxed for 2 hours and then cooled. Thereto was added water. The mixture was subjected to extraction with ethyl acetate twice. The organic layer was dried over anhydrous magnesium sulfate and then concentrated to obtain an oily material. The oily material was purified by silica gel column chromatography using a mixed solvent of chloroform/methanol=40/1 to obtain 1.88 g of oily 1-(4-bromophenyl)-3-[4-(2-methoxyphenyl)piperazine-1-yl]methyl-2-pyrrolidinone.
- 1H-NMR (CDCl3, δ ppm): 2.03-2.17 (1H, m), 2.34-2.46 (1H, m), 2.60-3.20 (11H, m), 3.70-3.89 (2H, m), 3.87 (3H, s), 6.85-7.04 (4H, m), 7.45-7.59 (4H, m)
- Production of 1-(4-bromophenyl)-3-pyrrolidinomethyl-2-pyrrolidinone
- There were mixed 1.31 g of 1-(4-bromophenyl)-3-methylene-2-pyrrolidinone, 2.00 g of 4-(2-methoxyphenyl)piperazine and 5 ml of pyrrolidine. The mixture was refluxed for 1 hour and then cooled. Thereto was added water. The mixture was subjected to extraction with ethyl acetate twice. The organic layer was dried over anhydrous magnesium sulfate and concentrated. The residue was purified by silica gel column chromatography using a mixed solvent of chloroform/methanol=40/1 to obtain 1.79 g of 1-(4-bromophenyl)-3-pyrrolidinomethyl-2-pyrrolidinone.
- 1H-NMR (CDCl3, δ ppm): 1.74-1.84 (4H, m), 2.01-2.15 (1H, m), 2.34-2.45 (1H, m), 2.51-2.88 (6H, m), 2.94-3.00 (1H, m), 3.75-3.80 (2H, m), 7.46 (2H, d), 7.55 (2H, d)
Claims (10)
1. A process for producing a pyrrolidinone compound represented by the formula (1):
[wherein R1 is an alkyl group of 1 to 12 carbon atoms or a substituent represented by the formula (2):
(wherein R2 is a hydrogen atom, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a hydroxyl group, a cyano group, an amino group, a nitro group, a carbamoyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carboxyl group; p is an integer of 1 to 5; when p is 2 or more, each R2 independently has the same definition as given above; and j is an integer of 0 to 2), and Q is a substituent represented by the formula (3a), (3b), (3c) or (3d):
{in the formula (3a), R3 and R4 are each independently a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, and R3 and R4 may bond to each other to form a morpholine ring; in the formula (3b), m and n are each independently an integer of 1 to 4, X is a hydrogen atom, a hydroxyl group, a cyano group, a carbamoyl group, a halogen atom or an alkyl group of 1 to 4 carbon atoms, and Y is a hydrogen atom, an alkyl group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, or a substituted or unsubstituted phenyl group; in the formula (3c), W is an alkyl group of 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group; and in the formula (3d), m and n are each independently an integer of 1 to 4, Z is a hydrogen atom, an alkyl group of 1 to 18 carbon atoms, a substituted or unsubstituted phenyl group, an alkyl group of 1 to 2 carbon atoms substituted with a substituted or unsubstituted phenyl group, or a substituent represented by the formula (4):
—(CH2)k—OR5 (4)
(wherein k is an integer of 2 to 3; and R5is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms, an alkenyl group of 2 to 3 carbon atoms or an alkynyl group of 2 to 3 carbon atoms)}],
which process includes a step of reacting a compound represented by the formula (5):
(wherein R1 has the same definition as given above) with an amine derivative represented by the formula (6a), (6b), (6c) or (6d):
{in the formula (6a), R3 and R4 have the same definitions as given above; in the formula (6b), X, Y, m and n have the same definitions as given above; in the formula (6c), W has the same definition as given above; and in the formula (6d), Z, m and n have the same definitions as given above} in the presence of formaldehyde to produce a pyrrolidinone compound of the formula (1).
2. A process according to claim 1 , wherein a pyrrolidinone compound of the formula (1) {wherein R1 is a substituent represented by the formula (2a):
(wherein R2a is a hydrogen atom or a halogen atom; p is an integer of 1 to 5; when p is 2 or more, each R2a independently has the same definition as given above; and ja is 0), and Q is a substituent represented by the formula (7):
(wherein m and n are each independently an integer of 1 to 4; k is an integer of 2 to 3; and R5 is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms, an alkenyl group of 2 to 3 carbon atoms or an alkynyl group of 2 to 3 carbon atoms)} is produced by reacting a compound of the formula (5) {wherein R1 is a substituent represented by the formula (2a) (wherein R2a, p and ja have the same definitions as give above)} with an amine derivative represented by the formula (6d) {wherein Z is a substituent represented by the formula (4) (wherein k and R5 have the same definitions as given above)} in the presence of formaldehyde.
3. A process according to claim 2 , wherein a pyrrolidinone compound of the formula (1) {wherein R1 is a 4-chlorophenyl group and Q is a substituent represented by the formula (8):
4. A process according to claim 3 , wherein the amine derivative is a compound of the formula (9) wherein R6 is a methyl group.
6. A compound of the formula (5) according to claim 5 , wherein R1 is represented by the formula (2) (wherein R2 and p have the same definitions as given above, and j is 0); or a salt thereof.
7. A compound of the formula (5) according to claim 5 or 6, wherein R1 is a 4-chlorophenyl group; or a salt thereof.
8. A process for producing a compound represented by the formula (12):
(wherein R21 to R25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) which process includes a step of reacting a compound represented by the formula (13):
(wherein R21 to R25 have the same definitions as given above) with 1,1-cyclopropanedicarboxylic acid to produce a compound of the formula (12).
9. A process according to claim 8 , wherein R21, R22, R24 and R25 are each a hydrogen atom and R23 is a chlorine atom or a bromine atom.
10. A process according to claim 9 , wherein R23 is a chlorine atom.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/369,808 US20030171578A1 (en) | 1997-11-14 | 2003-02-21 | Pyrrolidinone derivative compound |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31378497A JP4286921B2 (en) | 1997-11-14 | 1997-11-14 | 3-carboxy-1-phenyl-2-pyrrolidinone derivatives and production method |
| JP313784/1997 | 1997-11-14 | ||
| JP31999497A JPH11152267A (en) | 1997-11-20 | 1997-11-20 | Production of pyrrolidinone derivative |
| JP319994/1997 | 1997-11-20 | ||
| US09/190,297 US6207825B1 (en) | 1997-11-14 | 1998-11-13 | Method for production of pyrrolidinone derivatives |
| US09/694,340 US6555694B1 (en) | 1997-11-14 | 2000-10-24 | Method for production of pyrrolidinone derivatives |
| US10/369,808 US20030171578A1 (en) | 1997-11-14 | 2003-02-21 | Pyrrolidinone derivative compound |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/694,340 Division US6555694B1 (en) | 1997-11-14 | 2000-10-24 | Method for production of pyrrolidinone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20030171578A1 true US20030171578A1 (en) | 2003-09-11 |
Family
ID=26567707
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/190,297 Expired - Fee Related US6207825B1 (en) | 1997-11-14 | 1998-11-13 | Method for production of pyrrolidinone derivatives |
| US09/694,340 Expired - Fee Related US6555694B1 (en) | 1997-11-14 | 2000-10-24 | Method for production of pyrrolidinone derivatives |
| US10/369,808 Abandoned US20030171578A1 (en) | 1997-11-14 | 2003-02-21 | Pyrrolidinone derivative compound |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/190,297 Expired - Fee Related US6207825B1 (en) | 1997-11-14 | 1998-11-13 | Method for production of pyrrolidinone derivatives |
| US09/694,340 Expired - Fee Related US6555694B1 (en) | 1997-11-14 | 2000-10-24 | Method for production of pyrrolidinone derivatives |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6207825B1 (en) |
| EP (1) | EP0916656B1 (en) |
| AT (1) | ATE249434T1 (en) |
| DE (1) | DE69817974T2 (en) |
| DK (1) | DK0916656T3 (en) |
| ES (1) | ES2205362T3 (en) |
| PT (1) | PT916656E (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8835668B2 (en) | 2010-08-23 | 2014-09-16 | Novartis Ag | Process for the preparation of intermediates for the manufacture of NEP inhibitors |
| US9067883B2 (en) | 2010-01-22 | 2015-06-30 | Novartis Ag | Intermediates of neutral endopeptidase inhibitors and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007058305A1 (en) * | 2005-11-18 | 2009-05-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Method for producing cinnamide derivative |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175157A (en) * | 1985-11-27 | 1992-12-29 | Boehringer Ingelheim Gmbh | Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them |
| ES2087097T3 (en) * | 1989-04-19 | 1996-07-16 | Otsuka Pharma Co Ltd | DERIVATIVES OF PHENYLCARBOXYLIC ACIDS CONTAINING A HETEROCICLE. |
| JPH02300119A (en) * | 1989-05-11 | 1990-12-12 | Kanegafuchi Chem Ind Co Ltd | Agent for suppressing formation of lipid peroxide |
| US5538985A (en) * | 1994-01-27 | 1996-07-23 | Mitsui Toatsu Chemicals, Inc. | Pyrrolidinone derivatives |
| JP3786983B2 (en) * | 1994-01-27 | 2006-06-21 | シエーリング アクチエンゲゼルシャフト | Pyrrolidinone derivative |
| GB9411008D0 (en) * | 1994-06-02 | 1994-07-20 | Zeneca Ltd | Herbicides |
| GB9510744D0 (en) * | 1995-05-26 | 1995-07-19 | Zeneca Ltd | Chemical process |
| JP4260911B2 (en) * | 1997-12-15 | 2009-04-30 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Method for racemization of pyrrolidinone derivatives |
| JP2000143624A (en) * | 1998-11-13 | 2000-05-26 | Mitsui Chemicals Inc | 3-carboxy-1-phenyl-2-pyrrolidinone derivative and its production |
-
1998
- 1998-11-13 AT AT98121178T patent/ATE249434T1/en not_active IP Right Cessation
- 1998-11-13 DK DK98121178T patent/DK0916656T3/en active
- 1998-11-13 EP EP98121178A patent/EP0916656B1/en not_active Expired - Lifetime
- 1998-11-13 ES ES98121178T patent/ES2205362T3/en not_active Expired - Lifetime
- 1998-11-13 US US09/190,297 patent/US6207825B1/en not_active Expired - Fee Related
- 1998-11-13 DE DE69817974T patent/DE69817974T2/en not_active Expired - Fee Related
- 1998-11-13 PT PT98121178T patent/PT916656E/en unknown
-
2000
- 2000-10-24 US US09/694,340 patent/US6555694B1/en not_active Expired - Fee Related
-
2003
- 2003-02-21 US US10/369,808 patent/US20030171578A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9067883B2 (en) | 2010-01-22 | 2015-06-30 | Novartis Ag | Intermediates of neutral endopeptidase inhibitors and preparation method thereof |
| US9278908B2 (en) | 2010-01-22 | 2016-03-08 | Novartis Ag | Intermediates of neutral endopeptidase inhibitors and preparation method thereof |
| US8835668B2 (en) | 2010-08-23 | 2014-09-16 | Novartis Ag | Process for the preparation of intermediates for the manufacture of NEP inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69817974D1 (en) | 2003-10-16 |
| EP0916656A2 (en) | 1999-05-19 |
| DE69817974T2 (en) | 2004-07-22 |
| US6207825B1 (en) | 2001-03-27 |
| PT916656E (en) | 2004-02-27 |
| ATE249434T1 (en) | 2003-09-15 |
| ES2205362T3 (en) | 2004-05-01 |
| US6555694B1 (en) | 2003-04-29 |
| EP0916656A3 (en) | 2001-04-11 |
| EP0916656B1 (en) | 2003-09-10 |
| DK0916656T3 (en) | 2004-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69700321T2 (en) | Process for the production of sildenafil | |
| EP0274379B1 (en) | Process for preparing pyridine-2,3-dicarboxylic acid compounds | |
| DE60210816T2 (en) | PROCESS FOR THE PREPARATION OF 1- (CARBOXYMETHYL) AND 1 (AMINOCARBONYL) -PYRIMIDIN-4-ON DERIVATIVES | |
| EP3495347A1 (en) | New process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine | |
| JPS63139182A (en) | Production of thiazolidinedione derivative | |
| SK128494A3 (en) | Method of production of indanylamine compounds | |
| KR20190013554A (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
| EP0452143B1 (en) | Process for preparing optically active 3-hydroxypyrrolidine derivatives | |
| US6207825B1 (en) | Method for production of pyrrolidinone derivatives | |
| EP0154490B1 (en) | Process for the preparation of pyrrolidone derivatives | |
| US6197969B1 (en) | Process for producing substituted alkylamines or salts thereof | |
| EP4136066A1 (en) | A process for preparation of substituted enamine compounds | |
| US5869694A (en) | Process for preparing 4-hydroxy-2-pyrrolidone | |
| US7271268B1 (en) | Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives | |
| DE69928454T2 (en) | Pyridazinone derivatives useful as intermediates for herbicides | |
| Cul et al. | Evaluation of N‐hydroxymethylphthalimide in alkaline medium: Novel entry to the tricyclic [1, 3] oxazepine core via an intramolecular π and O‐cationic cyclization | |
| Kirschke et al. | Surprising reactions or special azoolefins-self-arylation, indole ring closure, mild chlorine substitution, and “tert. amino effect” | |
| EP2240442B1 (en) | Preparation process useful in synthesis of atorvastatin | |
| US4632994A (en) | Process for decomposing N-oxide derivatives producing 5-vinyl-2-pyrrolidones | |
| JPH11152267A (en) | Production of pyrrolidinone derivative | |
| KR20190131983A (en) | Novel processes for preparing a diaminopyrimidine derivative or acid addition salt thereof | |
| PL152958B1 (en) | Method for manufacturing piperazine derivatives | |
| JP4286921B2 (en) | 3-carboxy-1-phenyl-2-pyrrolidinone derivatives and production method | |
| KR930005625B1 (en) | Process for producing amino-ketones | |
| KR100393744B1 (en) | A process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |